table_specific

What were the payments on debt for Brain Balance in 2024?

Brain_Balance Franchise · 2025 FDD

Answer from 2025 FDD Document

Years Ended December 31, 2024, 2023, and 2022
2024 2023 2022
Cash Flows from Operating Activities
Net (loss) income $(324,837) $ 161,876 $ 307,374
Adjustments to reconcile net (loss) income to net cash and
restricted cash from operating activities:
Depreciation and amortization 49,819 29,920 24,806
Credit loss expense 59,741 5,560 -
Changes in operating assets and liabilities that (used)
provided cash and restricted cash:
Accounts receivable (126,097) 42,623 (75,804)
Deferred franchise costs 20,050 23,393 19,952
Prepaid expenses and other assets (33,382) (10,615) 53,332
Accounts payable and accrued expenses (66,584) (46,246) 81,063
Deferred revenue 16,809 (89,332) (96,172)
Accrued advertising expenses (56,130) (98,824) 84,461
Net cash and restricted cash (used in) provided
by operating activities (460,611) 18,355 399,012
Cash Flows from Investing Activities
Issuance of notes receivable (61,946) - -
Purchases of website and software development assets (52,423) (146,179) (41,022)
Payments on notes receivable 31,221 - 20,000
Net cash and restricted cash used in investing
activities (83,148) (146,179) (21,022)
Cash Flows from Financing Activities
Advance to related party - - (422,848)
Payments on debt (3,515) (7,507) (3,006)
Member contribution 539,393 109,029 -
Net cash and restricted cash provided by (used
in) financing activities 535,878 101,522 (425,854)
Net Decrease in Cash and Restricted Cash (7,881) (26,302) (47,864)
Cash and Restricted Cash - Beginning of year 155,826 182,128 229,992
Cash and Restricted Cash - End of year $147,945 $ 155,826 $ 182,128
Classification of Cash and Restricted Cash
Cash $64,403 $ 21,796 $ 61,068
Restricted cash 83,542 134,030 121,060
$147,945 $ 155,826 $ 182,128
Total cash and restricted cash
Supplemental Cash Flow Information - Cash paid for interest $5,988 $ 5,671 $ 5,784
Significant Noncash Transactions - Amounts advanced to
related parties in 2022 and reclassified as distributions in 2022 $ - $ - $ 422,848

Source: Item 23 — RECEIPTS (FDD pages 72–292)

What This Means (2025 FDD)

According to Brain Balance's 2025 Franchise Disclosure Document, the payments on debt for the company in 2024 were $3,515. This figure is part of the cash flow statement, which provides an overview of the company's financial transactions during the specified period. The cash flow statement categorizes these transactions into operating, investing, and financing activities. Payments on debt are classified under cash flows from financing activities. This indicates the amount of cash Brain Balance used to reduce its outstanding debt obligations during the year.

For a prospective franchisee, understanding the franchisor's debt payments can offer insights into the financial health and stability of the company. Consistent and manageable debt payments suggest that the company is capable of meeting its financial obligations. However, it is important to consider this figure in conjunction with other financial metrics, such as revenue, net income, and total debt, to gain a comprehensive understanding of the company's financial situation.

It's also worth noting that the cash flow statement includes other relevant financial activities, such as net loss, depreciation and amortization, changes in accounts receivable, and member contributions. These figures can provide additional context for evaluating the overall financial performance of Brain Balance. Reviewing these figures in detail can help potential franchisees assess the financial risks and opportunities associated with investing in a Brain Balance franchise.

Franchisees should also compare these figures with previous years to identify any trends or significant changes in the company's financial performance. A thorough review of the franchisor's financial statements is a crucial step in the due diligence process for any prospective franchisee.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.